GlassScriptPhysician profile
Colin Nevins
NPI 1316304082
$29,541.35
in general payments reported to CMS, 2019-2025
9 companies · $3,592 in 2025
The $3,592 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,381 · 2022: $83.17 · 2024: $23K · 2025: $3,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $26K · Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $26,250.00 |
| Food and Beverage | $826.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2024 | |
| Smith+Nephew, INC. | $6,375.41 | 2024-2025 | Lens 4k |
| Kairos Surgical INC | $1,211.11 | 2021 | |
| Fortis Surgical, LLC | $1,170.11 | 2021 | |
| Cgg Medical INC | $322.95 | 2024-2025 | |
| Ossur Americas, INC. | $190.72 | 2024-2025 | Miami J, Unloader One X |
| Bioventus LLC | $114.47 | 2025 | Durolane |
| Ermi LLC | $83.17 | 2022 | |
| Stryker Corporation | $73.41 | 2025 | Iconix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Nevins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.